From August 13, Guangzhou citizens can make an appointment to vaccinate the recombinant COVID-19 vaccine (CHO cell) at the vaccination sites in each district, which is commonly referred to as the three dose vaccine. Recombinant vaccines, like inactivated vaccines, have good immunogenicity and safety, and citizens aged 18 and above who have not yet been vaccinated can rest assured to receive them. It is reported that 500000 recombinant COVID-19 vaccines have been launched in Guangzhou since August 13.

What is the name of the three injection COVID-19 vaccine
It is understood that the recombinant subunit vaccine approved for emergency use in China is the recombinant COVID-19 vaccine (CHO cell) jointly developed and produced by the Institute of Microbiology, Chinese Academy of Sciences and Anhui Zhifeilong Kema Biological Pharmaceutical Co., Ltd. (Zhifeilong Kema). It is reported that after three injections of vaccination, not only the neutralizing antibody level has doubled, but also can reach twice the level of COVID-19 rehabilitated patients, and the immune effect is more lasting.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!